These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 36656595)

  • 41. Asiatic acid ameliorates dextran sulfate sodium-induced murine experimental colitis via suppressing mitochondria-mediated NLRP3 inflammasome activation.
    Guo W; Liu W; Jin B; Geng J; Li J; Ding H; Wu X; Xu Q; Sun Y; Gao J
    Int Immunopharmacol; 2015 Feb; 24(2):232-238. PubMed ID: 25523461
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hydrogen sulfide protects against DSS-induced colitis by inhibiting NLRP3 inflammasome.
    Qin M; Long F; Wu W; Yang D; Huang M; Xiao C; Chen X; Liu X; Zhu YZ
    Free Radic Biol Med; 2019 Jun; 137():99-109. PubMed ID: 31026586
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Propionate catabolism by CD-associated adherent-invasive
    Agus A; Richard D; Faïs T; Vazeille E; Chervy M; Bonnin V; Dalmasso G; Denizot J; Billard E; Bonnet R; Buisson A; Barnich N; Delmas J
    Gut Microbes; 2021; 13(1):1-18. PubMed ID: 33769191
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Frontline Science: Specialized proresolving lipid mediators inhibit the priming and activation of the macrophage NLRP3 inflammasome.
    Lopategi A; Flores-Costa R; Rius B; López-Vicario C; Alcaraz-Quiles J; Titos E; Clària J
    J Leukoc Biol; 2019 Jan; 105(1):25-36. PubMed ID: 29601102
    [TBL] [Abstract][Full Text] [Related]  

  • 45. AIEC pathobiont instigates chronic colitis in susceptible hosts by altering microbiota composition.
    Chassaing B; Koren O; Carvalho FA; Ley RE; Gewirtz AT
    Gut; 2014 Jul; 63(7):1069-80. PubMed ID: 23896971
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Schisandra chinensis (Turcz.) Baill. Protects against DSS-induced colitis in mice: Involvement of TLR4/NF-κB/NLRP3 inflammasome pathway and gut microbiota.
    Bian Z; Qin Y; Li L; Su L; Fei C; Li Y; Hu M; Chen X; Zhang W; Mao C; Yuan X; Lu T; Ji D
    J Ethnopharmacol; 2022 Nov; 298():115570. PubMed ID: 35868549
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The zebrafish NLRP3 inflammasome has functional roles in ASC-dependent interleukin-1β maturation and gasdermin E-mediated pyroptosis.
    Li JY; Wang YY; Shao T; Fan DD; Lin AF; Xiang LX; Shao JZ
    J Biol Chem; 2020 Jan; 295(4):1120-1141. PubMed ID: 31852739
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Libertellenone M, a diterpene derived from an endophytic fungus Phomopsis sp. S12, protects against DSS-induced colitis via inhibiting both nuclear translocation of NF-κB and NLRP3 inflammasome activation.
    Fan M; Xiang G; Chen J; Gao J; Xue W; Wang Y; Li W; Zhou L; Jiao R; Shen Y; Xu Q
    Int Immunopharmacol; 2020 Mar; 80():106144. PubMed ID: 31927507
    [TBL] [Abstract][Full Text] [Related]  

  • 49. 1'-Acetoxychavicol acetate inhibits NLRP3-dependent inflammasome activation via mitochondrial ROS suppression.
    Sok SPM; Ori D; Wada A; Okude H; Kawasaki T; Momota M; Nagoor NH; Kawai T
    Int Immunol; 2021 Jun; 33(7):373-386. PubMed ID: 33830232
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A novel benzo[d]imidazole derivate prevents the development of dextran sulfate sodium-induced murine experimental colitis via inhibition of NLRP3 inflammasome.
    Liu W; Guo W; Wu J; Luo Q; Tao F; Gu Y; Shen Y; Li J; Tan R; Xu Q; Sun Y
    Biochem Pharmacol; 2013 May; 85(10):1504-12. PubMed ID: 23506741
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Inflammasome-targeting natural compounds in inflammatory bowel disease: Mechanisms and therapeutic potential.
    Xu Q; Sun W; Zhang J; Mei Y; Bao J; Hou S; Zhou X; Mao L
    Front Immunol; 2022; 13():963291. PubMed ID: 36090968
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Flavonoid VI-16 protects against DSS-induced colitis by inhibiting Txnip-dependent NLRP3 inflammasome activation in macrophages via reducing oxidative stress.
    Zhao Y; Guo Q; Zhu Q; Tan R; Bai D; Bu X; Lin B; Zhao K; Pan C; Chen H; Lu N
    Mucosal Immunol; 2019 Sep; 12(5):1150-1163. PubMed ID: 31152156
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Small molecule-driven mitophagy-mediated NLRP3 inflammasome inhibition is responsible for the prevention of colitis-associated cancer.
    Guo W; Sun Y; Liu W; Wu X; Guo L; Cai P; Wu X; Wu X; Shen Y; Shu Y; Gu Y; Xu Q
    Autophagy; 2014 Jun; 10(6):972-85. PubMed ID: 24879148
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The role of the microbiome and the NLRP3 inflammasome in the gut and lung.
    Donovan C; Liu G; Shen S; Marshall JE; Kim RY; Alemao CA; Budden KF; Choi JP; Kohonen-Corish M; El-Omar EM; Yang IA; Hansbro PM
    J Leukoc Biol; 2020 Sep; 108(3):925-935. PubMed ID: 33405294
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Activation of NLRP3 inflammasome contributes to the inflammatory response to allergic rhinitis via macrophage pyroptosis.
    Zhou H; Zhang W; Qin D; Liu P; Fan W; Lv H; Tan L; Gao Z; Xu Y
    Int Immunopharmacol; 2022 Sep; 110():109012. PubMed ID: 35809382
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Development of novel oridonin analogs as specifically targeted NLRP3 inflammasome inhibitors for the treatment of dextran sulfate sodium-induced colitis.
    Pang L; Liu H; Quan H; Sui H; Jia Y
    Eur J Med Chem; 2023 Jan; 245(Pt 2):114919. PubMed ID: 36399877
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Isoliquiritigenin Ameliorates Indomethacin-Induced Small Intestinal Damage by Inhibiting NOD-Like Receptor Family, Pyrin Domain-Containing 3 Inflammasome Activation.
    Nakamura S; Watanabe T; Tanigawa T; Shimada S; Nadatani Y; Miyazaki T; Iimuro M; Fujiwara Y
    Pharmacology; 2018; 101(5-6):236-245. PubMed ID: 29393276
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Titanium dioxide nanoparticles exacerbate DSS-induced colitis: role of the NLRP3 inflammasome.
    Ruiz PA; Morón B; Becker HM; Lang S; Atrott K; Spalinger MR; Scharl M; Wojtal KA; Fischbeck-Terhalle A; Frey-Wagner I; Hausmann M; Kraemer T; Rogler G
    Gut; 2017 Jul; 66(7):1216-1224. PubMed ID: 26848183
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Growth differentiation factor 11 ameliorates experimental colitis by inhibiting NLRP3 inflammasome activation.
    Wang L; Wang Y; Wang Z; Qi Y; Zong B; Liu M; Li X; Zhang X; Liu C; Cao R; Ma Y
    Am J Physiol Gastrointest Liver Physiol; 2018 Dec; 315(6):G909-G920. PubMed ID: 30188752
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prevalence of the pathobiont adherent-invasive Escherichia coli and inflammatory bowel disease: a systematic review and meta-analysis.
    Nadalian B; Yadegar A; Houri H; Olfatifar M; Shahrokh S; Asadzadeh Aghdaei H; Suzuki H; Zali MR
    J Gastroenterol Hepatol; 2021 Apr; 36(4):852-863. PubMed ID: 32929762
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.